Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
about
Of mice, cattle, and humans: the immunology and treatment of river blindnessHelminth infections: the great neglected tropical diseasesOnchocerciasis transmission in Ghana: the human blood index of sibling species of the Simulium damnosum complex.Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi InfectionDiscovery of anthelmintic drug targets and drugs using chokepoints in nematode metabolic pathwaysResearch for new drugs for elimination of onchocerciasis in AfricaKilling filarial nematode parasites: role of treatment options and host immune responseThe Potentials and Pitfalls of Microarrays in Neglected Tropical Diseases: A Focus on Human Filarial InfectionsNeglected tropical diseasesComparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot TrialGenetic selection of low fertile Onchocerca volvulus by ivermectin treatmentMining predicted essential genes of Brugia malayi for nematode drug targetsImmunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposureFunctional analysis of the cathepsin-like cysteine protease genes in adult Brugia malayi using RNA interferenceThe heme biosynthetic pathway of the obligate Wolbachia endosymbiont of Brugia malayi as a potential anti-filarial drug targetA novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motilityGlutamate-gated chloride channels of Haemonchus contortus restore drug sensitivity to ivermectin resistant Caenorhabditis elegansThe transcriptional response of Caenorhabditis elegans to Ivermectin exposure identifies novel genes involved in the response to reduced food intakeUncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasisDynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from CameroonThe cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case studyReproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from CameroonHuman Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination ProgrammeThe Validation of Nematode-Specific Acetylcholine-Gated Chloride Channels as Potential Anthelmintic Drug TargetsFunctional Characterization of a Novel Class of Morantel-Sensitive Acetylcholine Receptors in NematodesThe Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in MiceUsing C. elegans Forward and Reverse Genetics to Identify New Compounds with Anthelmintic ActivityYeast-Based High-Throughput Screens to Identify Novel Compounds Active against Brugia malayiDoes Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness?Stability and change in the distribution of cytospecies of the Simulium damnosum complex (Diptera: Simuliidae) in southern Ghana from 1971 to 2011Nematode.net update 2011: addition of data sets and tools featuring next-generation sequencing dataIvermectin - Old Drug, New Tricks?The contribution of mass drug administration to global health: past, present and future.Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.Computational prediction of essential genes in an unculturable endosymbiotic bacterium, Wolbachia of Brugia malayiThe potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial dataIvermectin resistance in Onchocerca volvulus: toward a genetic basisStage- and gender-specific proteomic analysis of Brugia malayi excretory-secretory products.A four-antigen mixture for rapid assessment of Onchocerca volvulus infection.Repositioning of an existing drug for the neglected tropical disease Onchocerciasis.
P2860
Q21144551-1B7D68CD-C7AB-4FC3-B315-3B4F9CCB3D8DQ24648324-0E97AAA2-9A86-4A82-A962-27A73E12B3C6Q26315231-CD1C331E-6CE7-4B77-8AE5-A4C13072D7A4Q27303702-E40E2CFC-1FC4-4A9F-A763-86DC50D8AF90Q27334315-D00FA029-9910-4A70-B25F-93F4C4058E3BQ28066402-AE83ED02-B33E-4DED-9530-00C06273CCFFQ28074470-19B70CF6-51EB-4CE2-AF84-AD31E9ED4D4FQ28079948-35D789F8-2B10-4F51-B79A-6F52336CB3F3Q28267545-1784266B-B629-4194-87A5-C791BAEE2FA1Q28468411-2D44A276-9FE8-42A8-9835-8DFAEF1BCA8CQ28469339-983BFD3E-52A8-404E-A994-0F0410F923DCQ28471588-6126D415-F9D6-45F7-B42F-F807F843916FQ28471815-2872A63D-52C8-4A09-9E88-8DAF67FA2FC4Q28474713-E82D0448-9C7F-4770-9168-746563C045FAQ28475720-D8F577B5-BB44-4D89-8431-EA473BFFFC41Q28476171-EC5547DF-7A2F-4ACB-B0F3-BC7818D9BF08Q28479352-3DB20F4F-6C1F-44E3-9CBC-6E78A2B6985FQ28480640-A485C52B-63B0-441F-A580-0FC63069F44DQ28487047-32DF759D-D259-464A-A659-F41332DBAB9FQ28487094-0A79B48D-F847-4D7B-A581-714EDE2D24D7Q28533627-6884494E-AF42-4799-8DD0-1F364882387DQ28538222-0689598D-81ED-498C-8B8C-E4DF70A99744Q28546650-044E4A44-B15D-4712-A385-31BAC60D32D4Q28548328-9A101182-E447-4809-AD7A-2FBB11AF428CQ28551220-1AFB8229-5EEE-40EF-8A24-78CB877889C2Q28552440-4D191DC6-2314-44C7-B301-EF83247B5024Q28552737-E7472829-1AF9-4129-8254-E449446BA8E3Q28552887-16CF7D80-DF0D-4AC5-861B-B28A2A5776C1Q28602538-0A4A0465-A8D8-4D99-A3C7-9555385D188EQ28691621-DB796374-8161-4129-B07E-FDF21535C729Q28740950-4A728D15-378B-4C55-85B4-CB59038502B4Q30250918-22170EC2-659A-466D-A6DB-CCC69FF3A460Q30388508-56FCB1A9-7F1F-4BE3-96FF-BC212830B7B4Q30481947-3CFD8923-7B0F-4F11-BD0D-070A3CC380B1Q30923985-6D43BEB7-B53A-4554-AE25-2936CDA59DF4Q30936469-A93DE75B-8D92-4BB8-8FD7-1E177A374D0CQ33305360-40BFAB2B-4332-4EFF-8CA7-BC11A3C39535Q33380182-091F9A81-F8C7-4A30-9C9C-4A219536E075Q33444694-567045C5-51DF-4966-9277-CD96B8615FADQ33530297-DF59B26F-85D6-4A91-9A19-9711E26BB21E
P2860
Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Prevalence and intensity of On ...... o-phase epidemiological study.
@ast
Prevalence and intensity of On ...... o-phase epidemiological study.
@en
Prevalence and intensity of On ...... o-phase epidemiological study.
@nl
type
label
Prevalence and intensity of On ...... o-phase epidemiological study.
@ast
Prevalence and intensity of On ...... o-phase epidemiological study.
@en
Prevalence and intensity of On ...... o-phase epidemiological study.
@nl
prefLabel
Prevalence and intensity of On ...... o-phase epidemiological study.
@ast
Prevalence and intensity of On ...... o-phase epidemiological study.
@en
Prevalence and intensity of On ...... o-phase epidemiological study.
@nl
P2093
P921
P1433
P1476
Prevalence and intensity of On ...... o-phase epidemiological study.
@en
P2093
Daniel A Boakye
Jeffrey K L Eng
John O Gyapong
Mike Y Osei-Atweneboana
Roger K Prichard
P304
P356
10.1016/S0140-6736(07)60942-8
P407
P577
2007-06-01T00:00:00Z